Researchers discovered that altering the body’s natural rhythm can help protect the brain from Alzheimer’s damage. By turning off a circadian protein in mice, they raised NAD+ levels and reduced ...

Glial cells have emerged as central regulators of neural homeostasis, immune surveillance, and disease propagation throughout ...

Central skull base osteomyelitis is a rare, life-threatening condition that can present with vague symptoms and may be missed ...

Growing research points to the Mediterranean diet as a potential modulator of inflammation, beta-amyloid deposition, and other pathways central to Alzheimer progression.

Inflammatory cardiomyopathy remains a challenging condition characterized by inflammation of the heart muscle, which often results from a diverse range of ...

Imaging data from the phase 2 MINDFuL trial in Alzheimer’s Disease should be released in Q4 2025. Final data on the INKmune CARE-PC trial is expected in Q4 2025. Financial Results for the Third ...

IBD research, for all its sophistication, has been searching under the lamppost — sequencing, mapping and quantifying what can be seen. But the key may lie in the park, in the unseen intersections of ...

Addressing the question of whether and how immune cells (macrophages) in the central nervous system (CNS) traffic out, ...

Addressing the question of whether and how immune cells (macrophages) in the central nervous system (CNS) traffic out, ...

Electra Therapeutics has completed an oversubscribed $183 million Series C financing it said will fund a global pivotal trial of its lead pipeline candidate, a frontline treatment for secondary ...

cDepartment of Neurology, Mayo Clinic Jacksonville, Jacksonville, FL, USA dDepartment of Quantitative Health Sciences, Mayo Clinic Jacksonville, Jacksonville, FL, USA eDepartment of Radiology, Mayo ...